Anna Klimczak

491 total citations
32 papers, 328 citations indexed

About

Anna Klimczak is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Gastroenterology. According to data from OpenAlex, Anna Klimczak has authored 32 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 13 papers in Gastroenterology. Recurrent topics in Anna Klimczak's work include Gastrointestinal Tumor Research and Treatment (13 papers), Gastric Cancer Management and Outcomes (9 papers) and Sarcoma Diagnosis and Treatment (7 papers). Anna Klimczak is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (13 papers), Gastric Cancer Management and Outcomes (9 papers) and Sarcoma Diagnosis and Treatment (7 papers). Anna Klimczak collaborates with scholars based in Poland, Italy and Hungary. Anna Klimczak's co-authors include Piotr Rutkowski, Iwona Ługowska, Tomasz Świtaj, Janusz Szemraj, Elżbieta Bylina, Michał Wągrodzki, Sławomir Falkowski, Hanna Koseła-Paterczyk, Katarzyna Kozak and Beata Jagielska and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Anna Klimczak

29 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Klimczak Poland 12 202 149 106 64 51 32 328
B. Bui-Nguyen France 10 340 1.7× 162 1.1× 187 1.8× 48 0.8× 94 1.8× 13 444
Jung Shin Lee South Korea 10 321 1.6× 313 2.1× 49 0.5× 73 1.1× 64 1.3× 18 477
Young Iee Park South Korea 11 294 1.5× 141 0.9× 95 0.9× 50 0.8× 208 4.1× 22 430
Eihab Abdelfatah United States 7 231 1.1× 379 2.5× 47 0.4× 130 2.0× 127 2.5× 17 561
Keita Uchino Japan 12 151 0.7× 215 1.4× 42 0.4× 86 1.3× 59 1.2× 40 357
Takayuki Aimoto Japan 13 207 1.0× 326 2.2× 68 0.6× 49 0.8× 305 6.0× 55 482
Ji Hyun Park South Korea 8 146 0.7× 123 0.8× 35 0.3× 62 1.0× 60 1.2× 22 307
Yuanxiang Guan China 10 244 1.2× 142 1.0× 67 0.6× 57 0.9× 122 2.4× 19 361
Junjie Hu China 9 119 0.6× 142 1.0× 15 0.1× 73 1.1× 60 1.2× 28 344
Victor Hugo Fonseca de Jesus Brazil 12 173 0.9× 247 1.7× 40 0.4× 70 1.1× 134 2.6× 57 410

Countries citing papers authored by Anna Klimczak

Since Specialization
Citations

This map shows the geographic impact of Anna Klimczak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Klimczak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Klimczak more than expected).

Fields of papers citing papers by Anna Klimczak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Klimczak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Klimczak. The network helps show where Anna Klimczak may publish in the future.

Co-authorship network of co-authors of Anna Klimczak

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Klimczak. A scholar is included among the top collaborators of Anna Klimczak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Klimczak. Anna Klimczak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rutkowski, Piotr, Anna Klimczak, Paweł Teterycz, et al.. (2025). Avelumab plus axitinib in patients with advanced gastrointestinal stromal tumor. European Journal of Cancer. 225. 115565–115565.
2.
3.
Świtaj, Tomasz, Paweł Teterycz, Anna Klimczak, et al.. (2021). Efficacy of Sirolimus Treatment in PEComa–10 Years of Practice Perspective. Journal of Clinical Medicine. 10(16). 3705–3705. 15 indexed citations
4.
5.
Dansonka‐Mieszkowska, Agnieszka, Piotr Rutkowski, Anna Klimczak, et al.. (2021). Unique gastrointestinal stromal tumor with PDGFRA D842Y mutation—evaluation of in vivo sensitivity to imatinib. memo - Magazine of European Medical Oncology. 14(2). 208–213.
6.
Kozak, Katarzyna, Artur Kowalik, Bartosz Wasąg, et al.. (2020). Cell-free DNA BRAF V600E measurements during BRAF inhibitor therapy of metastatic melanoma: long-term analysis. Tumori Journal. 106(3). 241–248. 14 indexed citations
7.
Kozak, Katarzyna, Maria A. Pantaleo, Elena Fumagalli, et al.. (2020). 1667TiP A phase II, single arm study of avelumab in combination with axitinib in patients with unresectable/metastatic gastrointestinal stromal tumor after failure of standard therapy - AXAGIST. Annals of Oncology. 31. S990–S990. 4 indexed citations
8.
Rutkowski, Piotr, Marcin Ziętek, Bożena Cybulska-Stopa, et al.. (2020). The analysis of 3-year adjuvant therapy with imatinib in patients with high-risk molecular profiled gastrointestinal stromal tumors (GIST) treated in routine practice. European Journal of Surgical Oncology. 47(5). 1191–1195. 12 indexed citations
9.
Koseła-Paterczyk, Hanna, et al.. (2020). A durable complete response to immunotherapy in a patient with metastatic alveolar soft part sarcoma. Tumori Journal. 106(6). NP9–NP13. 6 indexed citations
10.
Rutkowski, Piotr, Elżbieta Bylina, Iwona Ługowska, et al.. (2018). Treatment outcomes in older patients with advanced gastrointestinal stromal tumor (GIST). Journal of Geriatric Oncology. 9(5). 520–525. 10 indexed citations
11.
Rutkowski, Piotr, Paweł Teterycz, Anna Klimczak, et al.. (2018). Blood neutrophil-to-lymphocyte ratio is associated with prognosis in advanced gastrointestinal stromal tumors treated with imatinib. Tumori Journal. 104(6). 415–422. 12 indexed citations
12.
Pieńkowski, Andrzej, Anna Szumera‐Ciećkiewicz, Hanna Koseła-Paterczyk, et al.. (2017). [The long-term treatment outcomes of adult osteosarcoma].. PubMed. 42(250). 158–164. 6 indexed citations
13.
Rutkowski, Piotr, Beata Jagielska, Elżbieta Bylina, et al.. (2017). The analysis of the long-term outcomes of sorafenib therapy in routine practice in imatinib and sunitinib resistant gastrointestinal stromal tumors (GIST)*. Współczesna Onkologia. 21(4). 285–289. 13 indexed citations
14.
Świtaj, Tomasz, Katarzyna Kozak, Hanna Koseła-Paterczyk, et al.. (2017). Long-term Results of Therapy with Sunitinib in Metastatic Alveolar Soft Part Sarcoma. Tumori Journal. 103(3). 231–235. 26 indexed citations
15.
Rutkowski, Piotr, Anna Klimczak, Iwona Ługowska, et al.. (2017). Long-term results of treatment of advanced dermatofibrosarcoma protuberans (DFSP) with imatinib mesylate – The impact of fibrosarcomatous transformation. European Journal of Surgical Oncology. 43(6). 1134–1141. 50 indexed citations
16.
Klimczak, Anna, et al.. (2016). Expression of MMP9, SERPINE1 and miR-134 as prognostic factors in esophageal cancer. Oncology Letters. 12(5). 4133–4138. 27 indexed citations
17.
Rutkowski, Piotr, Elżbieta Bylina, Anna Klimczak, et al.. (2012). The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study. BMC Cancer. 12(1). 107–107. 62 indexed citations
18.
Klimczak, Anna, et al.. (2012). Synthesis of new N-arylamino(2-furyl)methylphosphonic acid diesters, and in vitro evaluation of their cytotoxicity against esophageal cancer cells. Medicinal Chemistry Research. 22(2). 852–860. 20 indexed citations
19.
Klimczak, Anna, et al.. (2011). Przegląd genów zaangażowanych w etiopatogenezę płaskonabłonkowego nowotworu przełyku (ESCC). Postępy Biochemii. 57(1). 1 indexed citations
20.
Koseła-Paterczyk, Hanna, Tomasz Świtaj, Anna Klimczak, et al.. (2011). Trabectedin in patients with pre-treated advanced soft tissue sarcoma: a retrospective single center analysis. Współczesna Onkologia. 6. 367–371. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. Bui-Nguyen Breakdown of academic impact, for papers by Jung Shin Lee Breakdown of academic impact, for papers by Young Iee Park Breakdown of academic impact, for papers by Eihab Abdelfatah Breakdown of academic impact, for papers by Keita Uchino Breakdown of academic impact, for papers by Takayuki Aimoto Breakdown of academic impact, for papers by Ji Hyun Park Breakdown of academic impact, for papers by Yuanxiang Guan Breakdown of academic impact, for papers by Junjie Hu Breakdown of academic impact, for papers by Victor Hugo Fonseca de Jesus
Rankless by CCL
2026